A detailed history of Kidder Stephen W transactions in Novo Nordisk A S stock. As of the latest transaction made, Kidder Stephen W holds 2,640 shares of NVO stock, worth $277,358. This represents 0.09% of its overall portfolio holdings.

Number of Shares
2,640
Previous 2,950 10.51%
Holding current value
$277,358
Previous $421,000 25.42%
% of portfolio
0.09%
Previous 0.13%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$119.07 - $145.42 $36,911 - $45,080
-310 Reduced 10.51%
2,640 $314,000
Q2 2024

Aug 12, 2024

SELL
$122.71 - $146.91 $14,725 - $17,629
-120 Reduced 3.91%
2,950 $421,000
Q4 2023

Feb 13, 2024

SELL
$87.78 - $105.45 $9,655 - $11,599
-110 Reduced 3.46%
3,070 $317,000
Q3 2023

Nov 14, 2023

BUY
$90.94 - $199.54 $139,138 - $305,296
1,530 Added 92.73%
3,180 $289,000
Q2 2023

Aug 11, 2023

SELL
$155.98 - $172.65 $15,597 - $17,265
-100 Reduced 5.71%
1,650 $267,000
Q1 2023

May 10, 2023

BUY
$132.34 - $159.14 $3,308 - $3,978
25 Added 1.45%
1,750 $278,000
Q4 2022

Feb 09, 2023

SELL
$102.55 - $135.33 $35,892 - $47,365
-350 Reduced 16.87%
1,725 $233,000
Q3 2022

Nov 08, 2022

SELL
$95.28 - $116.93 $7,146 - $8,769
-75 Reduced 3.49%
2,075 $207,000
Q2 2022

Jul 19, 2022

SELL
$103.24 - $121.81 $5,162 - $6,090
-50 Reduced 2.27%
2,150 $240,000
Q1 2022

May 17, 2022

BUY
$93.1 - $112.54 $204,820 - $247,588
2,200 New
2,200 $244,000
Q4 2021

Feb 08, 2022

SELL
$95.88 - $117.08 $206,142 - $251,722
-2,150 Closed
0 $0
Q3 2021

Nov 10, 2021

BUY
$84.42 - $106.62 $181,503 - $229,233
2,150 New
2,150 $206,000
Q1 2018

Apr 24, 2018

SELL
$48.49 - $58.14 $200,021 - $239,827
-4,125 Closed
0 $0
Q4 2017

Feb 02, 2018

SELL
$47.53 - $53.73 $23,765 - $26,865
-500 Reduced 10.81%
4,125 $221,000
Q3 2017

Oct 26, 2017

BUY
$41.15 - $49.22 $190,318 - $227,642
4,625
4,625 $223,000

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $237B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Kidder Stephen W Portfolio

Follow Kidder Stephen W and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Kidder Stephen W, based on Form 13F filings with the SEC.

News

Stay updated on Kidder Stephen W with notifications on news.